News
Rare diseases foundation and OncoThAI
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
Photodynamic Therapy and Photodiagnosis Update – September 2018
OncoThAI attended the European Photodynamic Therapy and Photodiagnosis Update conference from September 18th to 22nd 2018 in Kochel (Germany)
Photodynamic Therapy and Photodiagnosis Update 2020
Save the date: Update PDT-PDD 2020 will be held in Nancy, France!
Analysis phase of PHOS-ISTOS clinical trial is now achieved
This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
Enrollment phase of INDYGO is now successfully achieved
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
Special issue of the Lasers in Surgery and Medicine journal
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
Industrial development of PhoS-Istos project
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
OncoThAI at the ASLMS 2018 annual congress in Dallas, TX
OncoThAI researchers presented their latest works during the ASLMS 2018 conference in Dallas
OncoThAI work reported in the French weekly journal Le Point (April 5th, 2018)
OncoThAI work reported in the French weekly journal Le Point (April 5th, 2018)
Page 4 of 7
